Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. A. Polis

Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients With or Without HIV Infection

HIV Clinical Trials

2013

English

Clinical Pharmacokinetics of Cidofovir in Human Immunodeficiency Virus- Infected Patients

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

1995

English

Related publications

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients

Journal of the International AIDS Society

English

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

Journal of Acquired Immune Deficiency Syndromes

Infectious Diseases

Pharmacology

2009

English

The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy

PLoS ONE

Multidisciplinary

2016

English

Hepatitis B Virus Variants in an HIV-HBV Co-Infected Patient at Different Periods of Antiretroviral Treatment With and Without Lamivudine

BMC Infectious Diseases

Infectious Diseases

2004

English

Tenofovir (TDF) Has Stronger Antiviral Effect Than Adefovir (ADV) Against Lamivudine (LAM)-resistant Hepatitis B Virus (HBV)

Hepatology International

Hepatology

2008

English

Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil

Gut

Gastroenterology

2006

English

Lamivudine Treatment for Severe Acute HBV Hepatitis

International Journal of Medical Sciences

Medicine

2008

English

Comparative Evaluation of Baseline Characteristics of HIV Mono Infected and HIV/HBV Co Infected Cohort in Eastern India

BMC Infectious Diseases

Infectious Diseases

2014

English

Liver Transplantation for Patients With Lamivudine-Resistant HBV: What Is the Optimal Prophylactic Strategy?

Liver Transplantation

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. A. Polis

Baseline CD4+ T-Cell Counts Predict HBV Viral Kinetics to Adefovir Treatment in Lamivudine-Resistant HBV-Infected Patients With or Without HIV Infection

Clinical Pharmacokinetics of Cidofovir in Human Immunodeficiency Virus- Infected Patients

Related publications

HIV Lamivudine Resistance Mutations in HBV Co-Infected Romanian Patients

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy

Hepatitis B Virus Variants in an HIV-HBV Co-Infected Patient at Different Periods of Antiretroviral Treatment With and Without Lamivudine

Tenofovir (TDF) Has Stronger Antiviral Effect Than Adefovir (ADV) Against Lamivudine (LAM)-resistant Hepatitis B Virus (HBV)

Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil

Lamivudine Treatment for Severe Acute HBV Hepatitis

Comparative Evaluation of Baseline Characteristics of HIV Mono Infected and HIV/HBV Co Infected Cohort in Eastern India

Liver Transplantation for Patients With Lamivudine-Resistant HBV: What Is the Optimal Prophylactic Strategy?